COVID‑19 Accelerates Cardiac Ageing via p53–miR‑145 Axis Collapse and PVT1/IL‑11/IL‑33‑Mediated Lymphatic Degeneration
This paper proposes that SARS-CoV-2 infection accelerates cardiac ageing by disrupting the p53–miR-145 axis, which triggers a PVT1/IL-11/IL-33-mediated inflammatory cascade leading to lymphatic degeneration, chronic myocardial inflammation, and structural heart damage.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human heart is not merely a pump; it is a complex organ that ages alongside the rest of the body, gradually losing its ability to repair itself and maintain a clean, balanced internal environment. A key part of this maintenance system involves a network of tiny chemical signals that tell cells when to grow, when to rest, and when to die. Among these signals are microRNAs, which act like dimmer switches, turning down the volume on genes that might cause trouble if left running too loud. One such gene, known as p53, is a master regulator that helps keep the heart's structure intact and its immune system calm. When this regulatory network functions correctly, the heart stays resilient. When it breaks down, the organ can begin to deteriorate, leading to chronic inflammation, fluid buildup, and a higher risk of failure. Understanding how this delicate balance is maintained is crucial, because if we can identify what breaks it, we might be able to stop the heart from aging prematurely.
A new conceptual study proposes a specific reason why the heart of a person who has recovered from COVID-19 often shows signs of rapid aging, even if the infection itself was mild. The researchers suggest that the virus triggers a chain reaction that dismantles the heart's natural defense system. They propose that SARS-CoV-2 infection suppresses a vital microRNA called miR-145, which is normally kept active by the p53 gene. Under normal conditions, miR-145 acts as a brake on a protein called c-Myc, which drives cell growth. When the virus lowers the levels of miR-145, this brake is released, allowing c-Myc to rise unchecked. This surge in c-Myc then turns on a long strand of genetic material known as PVT1, which is associated with aging.
The rise of PVT1 sets off a second wave of damage. This genetic strand suppresses two other protective microRNAs, miR-23a and miR-15b-5p. These two molecules normally keep a check on two inflammatory signals, IL-11 and IL-33. With their suppressors gone, levels of IL-11 and IL-33 spike. These signals are potent drivers of inflammation and tissue scarring. In the heart, high levels of IL-33 are particularly destructive to the lymphatic system, which is the network of vessels responsible for draining fluid and waste from the heart muscle. The study indicates that IL-33 causes the cells lining these lymphatic vessels to die, leading to a thinning and loss of the vessels themselves.
This collapse of the lymphatic drainage system explains many of the lingering symptoms seen in survivors. Without working lymphatic vessels, fluid cannot leave the heart muscle, leading to persistent swelling. Immune cells that should have moved on get trapped in the tissue, causing chronic inflammation. The lack of drainage also creates an environment where blood clots are more likely to form, further damaging the heart's tiny blood vessels. The researchers map this entire process as a single, unified pathway: the virus knocks out the initial microRNA switch, which unleashes a cascade of genetic changes that ultimately destroys the heart's ability to clear waste and control inflammation.
The author emphasizes that this mechanism mirrors the changes seen in a naturally aged heart, suggesting that the virus forces the heart to skip decades of gradual wear and tear in a short period. They identify the p53 gene and its associated network as a master longevity system that protects the heart's structure, and they argue that its collapse is the root cause of the accelerated aging observed after infection. While this work is a theoretical model built from existing scientific data rather than a new set of experiments, it offers a clear explanation for why the heart struggles to recover. By pinpointing the specific steps in this chain reaction, the study highlights potential targets for future treatments, such as restoring the missing microRNA or blocking the inflammatory signals, which could help preserve the heart's health long after the virus has been cleared.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.